Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones05-29

DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 4.00% to $1.30 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.91% to 26,917.47 and the Dow Jones Industrial Average rising 0.05% to 50,668.97.

The stock's rise snapped a two-day losing streak.

Inovio Pharmaceuticals Inc. closed 56.36% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.21% to $230.80, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.27% to $26.14.

Trading volume (1.4 M) remained 1.7 million below its 50-day average volume of 3.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

May 28, 2026 17:24 ET (21:24 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2639461169?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-29 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639461169","market":"hk","top_or_hot":-1,"title":"Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> rose 4.00% to $1.30 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.91% to 26,917.47 and the Dow Jones Industrial Average  rising 0.05% to 50,668.97. \n</p>\n<p>\n     The stock's rise snapped a two-day losing streak. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 56.36% below its 52-week high of $2.98, which the company achieved on September 9th. \n</p>\n<p>\n     The stock outperformed some of its competitors Thursday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.21% to $230.80, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma</a> Inc. (STAB) remained unchanged, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.27% to $26.14. \n</p>\n<p>\n     Trading volume (1.4 M) remained 1.7 million below its 50-day average volume of 3.0 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2026 17:24 ET (21:24 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-29 05:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> rose 4.00% to $1.30 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.91% to 26,917.47 and the Dow Jones Industrial Average  rising 0.05% to 50,668.97. \n</p>\n<p>\n     The stock's rise snapped a two-day losing streak. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 56.36% below its 52-week high of $2.98, which the company achieved on September 9th. \n</p>\n<p>\n     The stock outperformed some of its competitors Thursday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.21% to $230.80, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma</a> Inc. (STAB) remained unchanged, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.27% to $26.14. \n</p>\n<p>\n     Trading volume (1.4 M) remained 1.7 million below its 50-day average volume of 3.0 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2026 17:24 ET (21:24 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4568","symbol_name":"美国抗疫概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2639461169","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2639461169","pubTimestamp":1780003440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  rose 4.00% to $1.30 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.91% to 26,917.47 and the Dow Jones Industrial Average  rising 0.05% to 50,668.97.The stock's rise snapped a two-day losing streak.Inovio Pharmaceuticals Inc. closed 56.36% below its 52-week high of $2.98, which the company achieved on September 9th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  fell 0.21% to $230.80, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 0.27% to $26.14.Trading volume  remained 1.7 million below its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"BK4568":"美国抗疫概念","BK4583":"猴痘概念","BK4139":"生物科技","INO":"伊诺维奥制药"},"translate_title":"Inovio Pharmaceuticals Inc.股票在强劲交易日表现优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INO":1.98},"content_text":"DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 4.00% to $1.30 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.91% to 26,917.47 and the Dow Jones Industrial Average  rising 0.05% to 50,668.97. \n\n\n     The stock's rise snapped a two-day losing streak. \n\n\n     Inovio Pharmaceuticals Inc. closed 56.36% below its 52-week high of $2.98, which the company achieved on September 9th. \n\n\n     The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.21% to $230.80, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.27% to $26.14. \n\n\n     Trading volume (1.4 M) remained 1.7 million below its 50-day average volume of 3.0 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2026. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2026 17:24 ET (21:24 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2639461169","isCrawlerRequest":true}